TCL Archive First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma February 22, 2013
TCL Archive Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients December 4, 1981
TCL Archive Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds May 27, 2011
TCL Archive In Brief: Albert and Mary Lasker Foundation announce 2014 award winners September 12, 2014
TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998
